Roche Diabetes Care, company of the Roche Pharmaceutical Group focused on the development of diabetes solutions, has appointed the American Lisa Huse new general director in Spain.
Huse, who until now held the position of Marketing, Strategy and Innovation Vice President in Roche Diagnostic Corp. for the Diabetes area, replaces Lars Kalfhaus in office, who assumes the role of Director General of Roche Diabetes Care in Germany.
The directive, a degree in Economics from the American University of Depauw, joined Roche Diagnostics in 1998 and has held various positions of responsibility in the areas of marketing, product and sales in Indianapolis (United States), as reported by the multinational in arelease.
Born at the end of 2015, Roche Diabetes Care Spain is based in Sant Cugat del Vallès (Barcelona) and employs about 200 people.
This young company is focused on innovation in the field of management and the treatment of chronic diseases, especially diabetes, aleoning that almost 6 million people suffer in Spain.
The firm, previously under Roche Diagnostics umbrella, integrates the devices brand for the measurement of blood cells and treatment of ACCU-Chek diabetes and the company for the development of digital solutions for the management of diabetes Emminens Healthcare Services, in additionof the IT HUB, a global computer development center, and the ICC, an international 'call center for personalized care for patients, clients and health professionals.
The company offers new solutions for the personalized management of diabetes, connecting patients, professionals and health managers, and also offers population planning and management services with diabetes for administrations.